We are one of eleven National Institute for Health Research (NIHR) MedTech and In vitro diagnostics Co-operatives (MICs) awarded funding by the NIHR, acting as a centre of expertise focusing on clinical areas of high burden of disease and unmet need for NHS patients across the UK.
Our focus is on cardiovascular disease; more than 7 million people in the UK are living with cardiovascular disease, which remains the UK’s biggest killer and the NHS spends a significant proportion of its budget on treatment and prevention of cardiovascular disease.
With a focus on devices, we are more appropriately referred to as a ‘MedTech Co-operative’. We work in partnership with patients and patient groups, front-line staff, leading expert researchers, and the technology and device industry. Our aim is to develop healthcare solutions which will improve clinical care and outcomes for patients suffering from a wide range of cardiovascular conditions, with economic benefit to the National Health Service (NHS).